MIM
AH

Merion Investment Management’s Accretive Health AH Stock Holding History

Merion Investment Management’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-25,000
Closed -$195K – 22
2014
Q2 		$195K Hold
25,000
– – 2.17% 18
2014
Q1 		$201K Buy
+25,000
New +$221K 3.19% 14

Other funds holding AH

Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
ACM
Accipiter Capital Management Palm Beach Gardens, Florida $124M AUM 6.47% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
BCM
Breithorn Capital Management New York $141M AUM 41.82% 1-Year Est. Return
RMC
Regis Management Company Menlo Park, California $331M AUM 14.13% 1-Year Est. Return
ECM
EII Capital Management New York $774K AUM 22.41% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Merion Investment Management's AH Position: Q3 2014 in Review

Merion Investment Management sold out of Accretive Health (AH) in Q3 2014, closing a stake of 25,000 shares — an estimated $195K sold.

Merion Investment Management first reported a position in AH in Q1 2014 and held it in 2 quarters. The position peaked at $201K in Q1 2014. 7 funds tracked by Wall St. Rank hold AH as of Q3 2014.

  • Merion Investment Management reported no remaining Accretive Health position as of Q3 2014 after selling out during the quarter.
  • Merion Investment Management sold 25,000 Accretive Health shares in Q3 2014, an estimated $195K.
  • Merion Investment Management first reported a position in Accretive Health in Q1 2014 and held it in 2 quarters.
  • Merion Investment Management's Accretive Health position peaked at $201K in Q1 2014.
  • 7 funds tracked by Wall St. Rank held Accretive Health as of Q3 2014.

Based on Merion Investment Management's 13F filing for Q3 2014, filed 14 Nov 2014.